Resilient Biotics is developing live biotherapeutics to decrease or replace antibiotics in the animal health industry. Our lead product is novel biotherapeutic specifically targeted to respiratory tract systems in an effort to prevent respiratory disease outbreaks in livestock herds. Read on to learn about our lead product.
Bovine Respiratory Disease
Bovine Respiratory Disease (BRD) is complex respiratory infection and represents a major profitability threat to the beef industry. It remains the primary cause of morbidity and mortality in cattle feed yards. With a number of viral and opportunistic bacterial agents, it has been difficult to control. Resilient has developed a novel way to treat BRD via restoration of a healthy respiratory tract microbiome. Our treatment is based on extensive analysis of microbial dysbiosis during disease onset, and we have designed a therapeutic cocktail to exclude opportunistic pathogens and promote beneficial host immune response.
